The study led by researchers at UCL and Imperial College London collaborating with partners at the University of Cambridge and the University of Oxford, comes ten years after the first such case, known as the ‘Berlin Patient.’ Both patients were treated with stem cell transplants from donors carrying a genetic mutation that prevents expression of
Scotland is set to become the first UK nation to routinely offer HIV pre-exposure prophylaxis to eligible patients after the Scottish Medicines Consortium backed the use of Gilead’s Truvada along with four other new therapies to be funded by the NHS. In clinical trials Truvada (emtricitabine/tenofovir disoproxil) was revealed to cut the relative risk of
A court in England has recently ruled that NHS England can pay for Gilead’s Truvada for use in HIV prevention, after campaigners took legal action over the refusal to fund it. Earlier this summer NHS England had refused to pay for Truvada, saying that it was down to councils to fund preventive treatments. In a
